Less G(2) arrest in irradiated cells of breast cancer patients than in female controls: a contribution to their enhanced chromosomal radiosensitivity?
AffiliationPaterson Institute for Cancer Research, Christie Hospital NHS Trust, Manchester M20 4BX, UK. firstname.lastname@example.org
MetadataShow full item record
AbstractPURPOSE: To determine if the efficacy of G(2) checkpoint control (measured as the degree of mitotic inhibition) was reduced in breast cancer patients (n=129) compared with healthy controls (n=105) after exposure of lymphocytes to X-rays. We had previously shown that the average level of radiation-induced chromosome damage was higher in G(2) lymphocytes of these patients than in the controls, and it was proposed that this was a marker of low penetrance predisposition to cancer. MATERIALS AND METHODS: Proliferating lymphocytes were X-irradiated (50 cGy) and sampled at 90 min post-irradiation, which was the time of maximum mitotic inhibition of G(2) cells, expressed as the extent of reduction in the mitotic index in irradiated compared with unirradiated cells. RESULTS: Repeated measurements on 28 controls showed that there were reproducible differences in mitotic inhibition between individuals. Inhibition was significantly greater in female than in male controls (p=0.014), but less in patients than in female controls (p=0.009). There was a weak inverse correlation between the extent of inhibition and the amount of chromosome damage in all females (r=-0.15, p=0.043). CONCLUSIONS: The lesser mitotic inhibition in patients than in female controls might contribute to their greater mean G(2) chromosomal radiosensitivity. However, this hypothesis is not easily reconciled with other observations that (1) the significant difference in inhibition between the sexes in controls was not accompanied by any gender difference in radiosensitivity and (2) there was an inverse correlation between inhibition and age in controls, yet no age-related increase in radiosensitivity. There might, therefore, be no causal relationship between G(2) mitotic inhibition and chromosomal radiosensitivity.
CitationLess G(2) arrest in irradiated cells of breast cancer patients than in female controls: a contribution to their enhanced chromosomal radiosensitivity? 2003, 79 (6):405-11 Int. J. Radiat. Biol.
JournalInternational Journal of Radiation Biology
- Chromosomal radiosensitivity, cancer predisposition and response to radiotherapy.
- Authors: Scott D
- Issue date: 2000 May
- Chromosomal radiosensitivity in Ukrainian breast cancer patients and healthy individuals.
- Authors: Ryabchenko NM, Glavin OA, Shtefura VV, Anikushko MF
- Issue date: 2012 Jul
- Cell death mechanisms associated with G2 radiosensitivity in patients with prostate cancer and benign prostatic hyperplasia.
- Authors: Howe O, O'Malley K, Lavin M, Gardner RA, Seymour C, Lyng F, Mulvin D, Quinlan DM, Mothersill C
- Issue date: 2005 Nov
- Chromosomal in-vitro radiosensitivity of lymphocytes in radiotherapy patients and AT-homozygotes.
- Authors: Dunst J, Neubauer S, Becker A, Gebhart E
- Issue date: 1998 Oct
- G2 checkpoint control and G2 chromosomal radiosensitivity in cancer survivors and their families.
- Authors: Cadwell KK, Curwen GB, Tawn EJ, Winther JF, Boice JD Jr
- Issue date: 2011 Mar